Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of Duchenne Muscular Dystrophy (DMD) Therapeutics will have significant change from previous year. According to our latest study, the global Duchenne Muscular Dystrophy (DMD) Therapeutics market size is USD million in 2022 from USD 1300.3 million in 2021, with a change of % between 2021 and 2022. The global Duchenne Muscular Dystrophy (DMD) Therapeutics market size will reach USD 16430 million in 2028, growing at a CAGR of 43.7% over the analysis period.
The United States Duchenne Muscular Dystrophy (DMD) Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Duchenne Muscular Dystrophy (DMD) Therapeutics market, reaching US$ million by the year 2028. As for the Europe Duchenne Muscular Dystrophy (DMD) Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Duchenne Muscular Dystrophy (DMD) Therapeutics players cover Sarepta Therapeutics, PTC Therapeutics, Pfizer, and Bristol-Myers Squibb, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Duchenne Muscular Dystrophy (DMD) Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Exondys
Emflaza
Translarna
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Clinics
Home Care
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Sarepta Therapeutics
PTC Therapeutics
Pfizer
Bristol-Myers Squibb
Italfarmaco
Santhera Pharmaceuticals
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2017-2028
2.1.2 Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Duchenne Muscular Dystrophy (DMD) Therapeutics Segment by Type
2.2.1 Exondys
2.2.2 Emflaza
2.2.3 Translarna
2.3 Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Type
2.3.1 Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Duchenne Muscular Dystrophy (DMD) Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Home Care
2.5 Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Application
2.5.1 Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Application (2017-2022)
3 Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Player
3.1 Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Players
3.1.1 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Duchenne Muscular Dystrophy (DMD) Therapeutics by Regions
4.1 Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth (2017-2022)
4.3 APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth (2017-2022)
4.4 Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Country (2017-2022)
5.2 Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Type (2017-2022)
5.3 Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Region (2017-2022)
6.2 APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Type (2017-2022)
6.3 APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Duchenne Muscular Dystrophy (DMD) Therapeutics by Country (2017-2022)
7.2 Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Type (2017-2022)
7.3 Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast
10.1 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Forecast
10.1.3 APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Forecast
10.1.4 Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Forecast
10.1.5 Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Forecast
10.2 Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast
10.2.2 Canada Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast
10.2.3 Mexico Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast
10.2.4 Brazil Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast
10.3 APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Forecast by Region (2023-2028)
10.3.1 China Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast
10.3.2 Japan Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast
10.3.3 Korea Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast
10.3.4 Southeast Asia Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast
10.3.5 India Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast
10.3.6 Australia Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast
10.4 Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast
10.4.2 France Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast
10.4.3 UK Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast
10.4.4 Italy Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast
10.4.5 Russia Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast
10.5 Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast
10.5.2 South Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast
10.5.3 Israel Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast
10.5.4 Turkey Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast
10.5.5 GCC Countries Duchenne Muscular Dystrophy (DMD) Therapeutics Market Forecast
10.6 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Forecast by Type (2023-2028)
10.7 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Sarepta Therapeutics
11.1.1 Sarepta Therapeutics Company Information
11.1.2 Sarepta Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics Product Offered
11.1.3 Sarepta Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sarepta Therapeutics Main Business Overview
11.1.5 Sarepta Therapeutics Latest Developments
11.2 PTC Therapeutics
11.2.1 PTC Therapeutics Company Information
11.2.2 PTC Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics Product Offered
11.2.3 PTC Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 PTC Therapeutics Main Business Overview
11.2.5 PTC Therapeutics Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Duchenne Muscular Dystrophy (DMD) Therapeutics Product Offered
11.3.3 Pfizer Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb Duchenne Muscular Dystrophy (DMD) Therapeutics Product Offered
11.4.3 Bristol-Myers Squibb Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Bristol-Myers Squibb Main Business Overview
11.4.5 Bristol-Myers Squibb Latest Developments
11.5 Italfarmaco
11.5.1 Italfarmaco Company Information
11.5.2 Italfarmaco Duchenne Muscular Dystrophy (DMD) Therapeutics Product Offered
11.5.3 Italfarmaco Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Italfarmaco Main Business Overview
11.5.5 Italfarmaco Latest Developments
11.6 Santhera Pharmaceuticals
11.6.1 Santhera Pharmaceuticals Company Information
11.6.2 Santhera Pharmaceuticals Duchenne Muscular Dystrophy (DMD) Therapeutics Product Offered
11.6.3 Santhera Pharmaceuticals Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Santhera Pharmaceuticals Main Business Overview
11.6.5 Santhera Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Exondys
Table 3. Major Players of Emflaza
Table 4. Major Players of Translarna
Table 5. Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Type (2017-2022)
Table 8. Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Application (2017-2022)
Table 11. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue Market Share by Player (2020-2022)
Table 13. Duchenne Muscular Dystrophy (DMD) Therapeutics Key Players Head office and Products Offered
Table 14. Duchenne Muscular Dystrophy (DMD) Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Regions (2017-2022)
Table 19. Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Country (2017-2022)
Table 21. Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Type (2017-2022)
Table 23. Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Application (2017-2022)
Table 25. APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Region (2017-2022)
Table 27. APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Type (2017-2022)
Table 29. APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Application (2017-2022)
Table 31. Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Country (2017-2022)
Table 33. Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Type (2017-2022)
Table 35. Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Duchenne Muscular Dystrophy (DMD) Therapeutics
Table 44. Key Market Challenges & Risks of Duchenne Muscular Dystrophy (DMD) Therapeutics
Table 45. Key Industry Trends of Duchenne Muscular Dystrophy (DMD) Therapeutics
Table 46. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 52. Sarepta Therapeutics Details, Company Type, Duchenne Muscular Dystrophy (DMD) Therapeutics Area Served and Its Competitors
Table 53. Sarepta Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics Product Offered
Table 54. Sarepta Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Sarepta Therapeutics Main Business
Table 56. Sarepta Therapeutics Latest Developments
Table 57. PTC Therapeutics Details, Company Type, Duchenne Muscular Dystrophy (DMD) Therapeutics Area Served and Its Competitors
Table 58. PTC Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics Product Offered
Table 59. PTC Therapeutics Main Business
Table 60. PTC Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. PTC Therapeutics Latest Developments
Table 62. Pfizer Details, Company Type, Duchenne Muscular Dystrophy (DMD) Therapeutics Area Served and Its Competitors
Table 63. Pfizer Duchenne Muscular Dystrophy (DMD) Therapeutics Product Offered
Table 64. Pfizer Main Business
Table 65. Pfizer Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Pfizer Latest Developments
Table 67. Bristol-Myers Squibb Details, Company Type, Duchenne Muscular Dystrophy (DMD) Therapeutics Area Served and Its Competitors
Table 68. Bristol-Myers Squibb Duchenne Muscular Dystrophy (DMD) Therapeutics Product Offered
Table 69. Bristol-Myers Squibb Main Business
Table 70. Bristol-Myers Squibb Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Bristol-Myers Squibb Latest Developments
Table 72. Italfarmaco Details, Company Type, Duchenne Muscular Dystrophy (DMD) Therapeutics Area Served and Its Competitors
Table 73. Italfarmaco Duchenne Muscular Dystrophy (DMD) Therapeutics Product Offered
Table 74. Italfarmaco Main Business
Table 75. Italfarmaco Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Italfarmaco Latest Developments
Table 77. Santhera Pharmaceuticals Details, Company Type, Duchenne Muscular Dystrophy (DMD) Therapeutics Area Served and Its Competitors
Table 78. Santhera Pharmaceuticals Duchenne Muscular Dystrophy (DMD) Therapeutics Product Offered
Table 79. Santhera Pharmaceuticals Main Business
Table 80. Santhera Pharmaceuticals Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Santhera Pharmaceuticals Latest Developments
List of Figures
Figure 1. Duchenne Muscular Dystrophy (DMD) Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Type in 2021
Figure 7. Duchenne Muscular Dystrophy (DMD) Therapeutics in Hospitals
Figure 8. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Duchenne Muscular Dystrophy (DMD) Therapeutics in Clinics
Figure 10. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market: Clinics (2017-2022) & ($ Millions)
Figure 11. Duchenne Muscular Dystrophy (DMD) Therapeutics in Home Care
Figure 12. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market: Home Care (2017-2022) & ($ Millions)
Figure 13. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Application in 2021
Figure 14. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue Market Share by Player in 2021
Figure 15. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 17. APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 18. Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 20. Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Value Market Share by Country in 2021
Figure 21. Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Consumption Market Share by Type in 2021
Figure 22. Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Application in 2021
Figure 23. United States Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Region in 2021
Figure 28. APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Application in 2021
Figure 29. China Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Country in 2021
Figure 36. Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Type in 2021
Figure 37. Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Application in 2021
Figure 38. Germany Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Market Share by Application in 2021
Figure 46. Egypt Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 52. APAC Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 53. Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 55. United States Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. Canada Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. China Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Japan Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. Korea Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. India Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. Australia Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. Germany Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. France Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. UK Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Italy Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Russia Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. Spain Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. Israel Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size 2023-2028 ($ Millions)
